Effects of Virtual Reality-Based Education on Pre-treatment Anxiety, Post-treatment Experience, and Satisfaction Among Adult Patients Diagnosed With Cancer Receiving External Beam Radiotherapy in Oman
EBRT
2 other identifiers
interventional
122
1 country
1
Brief Summary
Introduction: External Beam Radiotherapy is a common strategy used in the treatment of various cancers, and the patient undergoing treatment using this strategy many times experiences anxiety and stress. While patient education is essential for anxiety management, traditional methods may not adequately address the complex needs of patients in Oman, where no standardized pre-treatment education protocols exist. Virtual Reality (VR) technology offers promising potential for enhancing patient education and reducing anxiety. Purpose/Aim: This study aims to evaluate the effectiveness of VR-based education in reducing anxiety levels, improving treatment experience, and increasing satisfaction among adult patients with cancer receiving external beam radiotherapy (EBRT) in Oman. Research Design: A randomized control trial will be conducted with 122 patients undergoing external beam radiotherapy from SQCCCRC (Sultan Qaboos Comprehensive Cancer Care \& Research Center) and the National Oncology Center (NOC) in Royal Hospital. These patients will be randomly allocated to either the intervention group (VR-based education) or the control group (standard education). The intervention group will view an educational VR video via immersive headsets, while the control group will receive standard care. Study Instruments: Anxiety levels will be measured using the State Anxiety Inventory (SAI), the Radiotherapy Experience Questionnaire (RTEQ) will be used to measure treatment experience, and the Patient Satisfaction Questionnaire (PSQ) will be used to measure patient satisfaction. Plan for Data Analysis: The Statistical Package for Social Sciences (SPSS) version 29 will be used for data analysis. Descriptive statistics in terms of mean, standard deviation, frequencies, and percentages will be used to summarize patient characteristics. Paired t-tests will be used to compare pre- and post-intervention anxiety levels within each group. Independent t-tests will be used to assess differences between the intervention and control groups. Analysis of Covariance (ANCOVA) will be used to control confounding variables such as age, education level, and baseline anxiety scores. Expected Outcomes: The researcher predicts that VR education will lower anxiety levels while delivering better patient experiences and higher satisfaction than traditional education methods. Current study findings will guide patient education protocol development and help to establish standardized pre-radiotherapy education guideline standards in Oman
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable cancer
Started Feb 2026
Shorter than P25 for not_applicable cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 22, 2025
CompletedStudy Start
First participant enrolled
February 9, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2026
CompletedFirst Posted
Study publicly available on registry
August 10, 2026
CompletedAugust 10, 2026
February 1, 2026
6 months
December 22, 2025
August 4, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Anxiety
▪ Anxiety is measured using the State-Trait Anxiety Inventory (STAI); the scale ranges from a minimum of 20 to a maximum of 80 per subscale, with higher scores indicating a worse outcome for anxiety
Up to 7 months
Secondary Outcomes (2)
Patient Experience
Up to 7 months
▪ Patient satisfaction
Up to 7 months
Study Arms (2)
VR-based education group (intervention group)
EXPERIMENTALThe intervention group will view an educational VR video via immersive headsets
The Control / Comparison group (standard education)
NO INTERVENTIONThe control group will receive standard care.
Interventions
an educational VR video via immersive headsets
Eligibility Criteria
You may qualify if:
- Adult patients aged 18 years or above
- Willing to participate
- Provide informed consent
- Scheduled for their first external beam radiotherapy treatment
You may not qualify if:
- Pediatric cancer patients
- Scheduled for head \& neck external beam radiotherapy
- Previously underwent radiotherapy treatment
- Have severe visual or hearing difficulties
- Require emergency radiotherapy treatment
- Have a history of psychiatric illness
- Require ICU admission
- Experience severe motion sickness or vertigo
- Unable to tolerate the VR headset
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ministry of Health, Royal Hospital
Muscat, Muḩāfaz̧at Masqaţ, 111, Oman
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Blinding Application: * Participants (single-blind): While the study mentions blinding, it states that the researcher will emphasize to participants the importance of not disclosing their group assignment to healthcare providers, implying participants will know their allocation (intervention or control group) to some extent but are instructed not to reveal it to others involved in their care. * Healthcare Providers/Clinical Staff: Healthcare providers will not be informed about the group allocations of the patients. * Researcher: The researcher will not be involved in delivering standard care to the participants to maintain blinding.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 22, 2025
First Posted
August 10, 2026
Study Start
February 9, 2026
Primary Completion
August 1, 2026
Study Completion
August 1, 2026
Last Updated
August 10, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share
All IPDs are confidential in this randomized clinical trial.